Persimmon Plc (LON:PSN – Get Rating) has earned an average rating of “Hold” from the seven ratings firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is GBX 1,961.17 ($23.89).
Several research firms recently commented on PSN. JPMorgan Chase & Co. dropped their price objective on Persimmon from GBX 2,530 ($30.82) to GBX 2,150 ($26.19) and set an “overweight” rating on the stock in a research note on Wednesday, November 9th. Berenberg Bank dropped their target price on Persimmon from GBX 1,700 ($20.71) to GBX 1,600 ($19.49) and set a “hold” rating on the stock in a research report on Friday, November 25th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on Persimmon from GBX 2,854 ($34.77) to GBX 1,207 ($14.71) and set a “hold” rating on the stock in a research report on Thursday, October 20th.
Persimmon Price Performance
Persimmon stock opened at GBX 1,296.50 ($15.80) on Thursday. Persimmon has a 12 month low of GBX 1,113.50 ($13.57) and a 12 month high of GBX 2,716 ($33.09). The company has a current ratio of 4.66, a quick ratio of 1.04 and a debt-to-equity ratio of 0.27. The business’s 50 day simple moving average is GBX 1,279.38 and its 200 day simple moving average is GBX 1,462.21. The company has a market cap of £4.14 billion and a price-to-earnings ratio of 563.70.
Persimmon Plc, together with its subsidiaries, operates as a house builder in the United Kingdom. The company offers family housing under the Persimmon Homes brand name; executive housing under the Charles Church brand name; and social housing under the Westbury Partnerships brand name. It also provides broadband services.
- Why Hershey Is a Sweet Recession Stock
- Will Amazon Stock Be Delivering for Investors in 2023?
- The Analysts Shift Trucking Sentiment Back into Forward
- The Institutions Book A Flight With Boeing
- 2 Biotechs Making Waves With A Single Product in their Pipeline
Receive News & Ratings for Persimmon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Persimmon and related companies with MarketBeat.com's FREE daily email newsletter.